Search clinical trials for: FACBC

Total 36 results

David M. Schuster, MD

Completed

FACBC for Recurrent Prostate Cancer

Recurrent Prostate Cancer

United States
Emory University

Completed

Anti-1-amino-3-[18F]Fluorocyclobutyl-1-carboxylic Acid (Anti-[18F](FACBC)Positron Emission Tomography (PET-CT) of the Breast

Breast Cancer

United States
Emory University

Withdrawn

FACBC for Head and Neck Cancers

Cancers of the Head and Neck
Blue Earth Diagnostics

Completed

Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC)

Prostatic Neoplasms

United States, Italy, Norway
University of Oxford
Blue Earth Diagnostics

Completed

Fluciclovine (18F) Imaging of Breast Cancer (FRONTIER)

Breast Cancer

United Kingdom
David M. Schuster, MD

Terminated

FACBC Positron Emission Tomography/Computed Tomography(PET/CT) Used in the Diagnosis of Primary Prostate Cancer

Prostate Cancers

United States
Emory University
National Cancer Institute (NCI)

Completed

Validation of FACBC for Detection of Metastasis Among High-risk Prostate Cancer Patients With Presumed Localized Disease (EDRN-FACBC)

Cancer

United States
Blue Earth Diagnostics
American College of Radiology; Syne Qua Non Limited; IND 2 Results LLC

Completed

18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment (LOCATE)

Prostate Cancer

United States
National Taiwan University Hospital

Recruiting

18F-FACBC PET/CT and the PSA Kinetics for PCa Patients With Biochemical Recurrence.

Biochemical Relapse Fo Malignant Neoplasm of Prostate

Taiwan
Emory University
Nihon Medi-Physics Co., Ltd.

Completed

Amino Acid Tracer (FACBC) Positron Emission Tomography for Lung Nodule (SPN)

Lung Cancer

United States
Bital Savir-Baruch
Blue Earth Diagnostics

Unknown

Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.

Cervical Cancer | Ovarian Epithelial Cancer | Endometrial Cancer

United States
Blue Earth Diagnostics
Syne Qua Non Limited; Innovate UK; IND 2 Results LLC

Completed

Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer (FALCON)

Cancer of the Prostate

United Kingdom
David M. Schuster, MD

Completed

Anti-3-[18F]FACBC Imaging of Parathyroid Adenomas

Parathyroid Disease

United States
OHSU Knight Cancer Institute
Oregon Health and Science University; Blue Earth Diagnostics

Recruiting

Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET

Prostate Cancer

United States
St. Olavs Hospital
Norwegian University of Science and Technology; Norwegian Cancer Society

Completed

Pre-operative PET-MR of High Risk Prostate Cancer Patients for Assessment of Cancer Aggressiveness and Lymph Node Status

Prostatic Neoplasms

Norway
Mayo Clinic
Blue Earth Diagnostics, Inc

Recruiting

18F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the Brain

Metastatic Intracranial Malignant Neoplasm | Recurrent Intracranial Neoplasm

United States
David M. Schuster, MD
National Cancer Institute (NCI)

Completed

FACBC PET/CT for Recurrent Prostate Cancer

Prostate Cancer

United States
Emory University
Blue Earth Diagnostics; Nihon Medi-Physics Co., Ltd.

Completed

FACBC Prostate Therapy Response

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center

Completed

The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer

Breast Cancer | Head and Neck Cancer | Prostate Cancer

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer

Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8

United States
Memorial Sloan Kettering Cancer Center

Completed

Imaging Brain Tumors With FACBC and Methionine

Brain Cancer | CNS Cancer

United States
Baptist Health South Florida
Blue Earth Diagnostics

Not yet recruiting

18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery (FACILITATE)

Brain Cancer | Brain Metastases | Brain Metastases, Adult

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal Disease

Metastatic Head and Neck Squamous Cell Carcinoma | Metastatic Squamous Cell Carcinoma in Cervical Lymph Node

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery

Glioblastoma

United States
Emory University
National Cancer Institute (NCI)

Completed

FACBC Outcomes for Post Prostatectomy

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
Columbia University

Completed

[18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors

Brain Cancer | Gliomas

United States
Emory University
National Cancer Institute (NCI); National Institutes of Health (NIH); Telix International...

Active, not recruiting

Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes

Prostate Adenocarcinoma

United States
Massachusetts General Hospital
Bayer

Completed

A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer

Prostate Cancer | Castration-resistant Prostate Cancer | Castration-resistant Prostate Cancer Metastatic to Bone

United States
Emory University
National Cancer Institute (NCI)

Completed

Targeted Fusion Biopsy of the Prostate

Prostatic Neoplasms

United States
Memorial Sloan Kettering Cancer Center
GE Healthcare

Completed

FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients

Breast Cancer

United States
ECOG-ACRIN Cancer Research Group

Not yet recruiting

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Glioblastoma, IDH-Wildtype
University of Minnesota

Unknown

Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia

Fanconi's Anemia
Jonsson Comprehensive Cancer Center

Completed

Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery (PSMA vs AXUMIN)

Recurrent Prostate Carcinoma

United States
Emory University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Active, not recruiting

Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Invasive Breast Lobular Carcinoma | Metastatic Breast Lobular Carcinoma

United States
National Cancer Institute (NCI)

Not yet recruiting

A Study Using a New Drug, Nivolumab, in Combination With Chemotherapy Drugs to Treat a Type of Cancer Called Nasopharyngeal Carcinoma (NPC)

Stage IV Nasopharyngeal Carcinoma AJCC v8 | Stage II Nasopharyngeal Carcinoma AJCC v8 | Stage III Nasopharyngeal Carcinoma AJCC v8
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Recruiting

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Biochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8

United States

Search clinical trials for: FACBC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations